February 9, 2025 - 14:26

UCLA Health is embarking on an innovative multi-site pilot study aimed at investigating the effects of a ketogenic diet on mood stabilization in teenagers and young adults diagnosed with bipolar disorder. This research will examine the potential benefits of combining a high-fat, low-carbohydrate diet with traditional mood stabilizing medications.
The ketogenic diet has gained popularity for its potential neurological benefits, and this study seeks to determine if it can also play a role in managing the mood swings associated with bipolar disorder. Researchers will closely monitor participants to assess changes in mood symptoms and overall mental health.
The study highlights the growing interest in dietary interventions as complementary treatments for mental health conditions. By focusing on a younger demographic, the research aims to provide valuable insights into holistic approaches for managing bipolar disorder. Results from this pilot study could pave the way for new treatment options that enhance the quality of life for young individuals facing this challenging condition.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...